// App-Quantinova.ai

AB1141 : RITUXIMAB CONVERTS PAEDIATRIC RHEUMATOID FACTOR POSITIVITY TO NEGATIVITY

Researchers

Presenter

  • E. Mosley

Principal Investigators

  • D. Hawley

  • R. Tattersall

  • A.M. McMahon

Medical Centers

  • Royal Hallamshire Hospital, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

Disease

  • Rheumatoid arthritis

  • Uveitis

Biomarkers

  • TNF Receptor Superfamily Member 1B

Drug/Treatment

  • Triamcinolone Hexacetonide

  • Hydroxychloroquine

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Triamcinolone acetonide

  • Oraprine

  • Methotrexate

  • Infliximab

  • Etanercept

  • CHS-0214

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved